ethR Family assigned · medium auto-curated

H37Rv Rv3855 · MTBC0 mtbc0_004088 · 216 aa · 4351659–4352309 MTBC0 (+) · RefSeq NP_218372.1

Genomic neighbourhood (genome browser)

Open in full genome browser →

This gene (outlined) in its genomic context; arrows are neighbouring genes coloured by verdict. Click any gene to navigate. Pan and zoom in the full browser.

Annotation: from legacy to revised

Legacy (H37Rv / Mycobrowser)HTH-type transcriptional repressor EthR
MTBC0 PGAP re-annotationHTH-type transcriptional regulator EthR
Revised (this work)HTH-type transcriptional regulator EthR. Pfam: TetR_N (PF00440.30), EthR_C (PF21313.3).
Functional category (TubercuList)regulatory proteins

Auto-curated: this verdict and function were generated by rules from PGAP + Pfam + Foldseek and have not been hand-reviewed.

In the literature (TB corpus sweep) 60 publications

60 TB publications mention this gene. 60 publications discuss this gene. Queried separately, 59 records carry a M. tuberculosis context and 4 a non-TB mycobacterial context (species named in the 4-record verified sample: M. smegmatis (3)). The three counts come from three distinct PubMed queries (each with its own context filter), so they neither partition the total nor need to add up to it.

5 of 60: the most recently indexed records of the curated sweep at its date, not necessarily the most recent papers on this gene — the exhaustive list below is later and broader and may hold newer ones.
PublicationDate
Effects of mutations in multiple Ethionamide-resistance-associated genes among Mycobacterium tuberculosis clinical isolates from China. doi:10.3389/fcimb.2025.1725219 2025
In silico discovery of potential novel anti-tuberculosis drug candidates from phytoconstituents of Chlorophytum borivilianum and Asparagus racemosus. doi:10.1016/j.heliyon.2025.e42859 2025
Generative AI, molecular docking and molecular dynamics simulations assisted identification of novel transcriptional repressor EthR inhibitors to target Mycobacterium tuberculosis. doi:10.1016/j.heliyon.2025.e42593 2025
Identification of Mycobacterium tuberculosis transcriptional repressor EthR inhibitors: Shape-based search and machine learning studies. doi:10.1016/j.heliyon.2024.e26802 2024
Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. doi:10.1016/j.jiph.2023.07.016 2023
68 records returned by the alias sweep (a separate sweep from the 60 above; both are shown, neither is exhaustive)

Searched as: Rv3855, ethR, Mb3885, ML0064c, MMAR_5405, MSMEG_6441, MAB_0984c — each in conjunction with a mycobacterial context term. Swept 2026-09-07.

PublicationJournalYear
Identification and characterization of ethR and ethA genes impacting the sensitivity of Mycobacterium abscessus to ethionamide. doi:10.1128/spectrum.00638-26 names it Microbiol Spectr 2026
Effects of mutations in multiple Ethionamide-resistance-associated genes among Mycobacterium tuberculosis clinical isolates from China. doi:10.3389/fcimb.2025.1725219 Front Cell Infect Microbiol 2025
In silico discovery of potential novel anti-tuberculosis drug candidates from phytoconstituents of Chlorophytum borivilianum and Asparagus racemosus. doi:10.1016/j.heliyon.2025.e42859 Heliyon 2025
Generative AI, molecular docking and molecular dynamics simulations assisted identification of novel transcriptional repressor EthR inhibitors to target Mycobacterium tuberculosis. doi:10.1016/j.heliyon.2025.e42593 names it Heliyon 2025
Identification of Mycobacterium tuberculosis transcriptional repressor EthR inhibitors: Shape-based search and machine learning studies. doi:10.1016/j.heliyon.2024.e26802 names it Heliyon 2024
Bioisosteric modification of Linezolid identified the potential M. tuberculosis protein synthesis inhibitors to overcome the myelosuppression and serotonergic toxicity associated with Linezolid in the treatment of the multi-drug resistance tuberculosis (MDR-TB). doi:10.1080/07391102.2023.2203254 J Biomol Struct Dyn 2024
Deciphering the emerging role of phytocompounds: Implications in the management of drug-resistant tuberculosis and ATDs-induced hepatic damage. doi:10.1016/j.jiph.2023.07.016 J Infect Public Health 2023
Fragment Merging Using a Graph Database Samples Different Catalogue Space than Similarity Search. doi:10.1021/acs.jcim.3c00276 J Chem Inf Model 2023
Genetic Characterization Conferred Co-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Isolates from Southern Xinjiang, China. doi:10.2147/IDR.S407525 Infect Drug Resist 2023
Increased Susceptibility of Mycobacterium tuberculosis to Ethionamide by Expressing PPs-Induced Rv0560c. doi:10.3390/antibiotics11101349 Antibiotics (Basel) 2022
How a PCR Sequencing Strategy Can Bring New Data to Improve the Diagnosis of Ethionamide Resistance. doi:10.3390/microorganisms10071436 Microorganisms 2022
New ethionamide boosters and EthR2: structural and energetic analysis. doi:10.1039/d1cp02853g Phys Chem Chem Phys 2021
In silico identification of novel chemical compounds with antituberculosis activity for the inhibition of InhA and EthR proteins from Mycobacterium tuberculosis. doi:10.1016/j.jctube.2021.100246 names it J Clin Tuberc Other Mycobact Dis 2021
Genome analyses of 174 strains of Mycobacterium tuberculosis provide insight into the evolution of drug resistance and reveal potential drug targets. doi:10.1099/mgen.0.000542 Microb Genom 2021
Transcriptional portrait of M. bovis BCG during biofilm production shows genes differentially expressed during intercellular aggregation and substrate attachment. doi:10.1038/s41598-020-69152-2 Sci Rep 2020
Fragment-Based Optimized EthR Inhibitors with in Vivo Ethionamide Boosting Activity. doi:10.1021/acsinfecdis.9b00277 names it ACS Infect Dis 2020
Global discovery the PstP interactions using Mtb proteome microarray and revealing novel connections with EthR. doi:10.1016/j.jprot.2020.103650 names it J Proteomics 2020
Mycobacterium tuberculosis topoisomerases and EthR as the targets for new anti-TB drugs development. doi:10.4155/fmc-2018-0232 names it Future Med Chem 2019
Relative Binding Energies Predict Crystallographic Binding Modes of Ethionamide Booster Lead Compounds. doi:10.1021/acs.jpclett.9b00741 J Phys Chem Lett 2019
A fragment-based approach towards the discovery of N-substituted tropinones as inhibitors of Mycobacterium tuberculosis transcriptional regulator EthR2. doi:10.1016/j.ejmech.2019.02.023 Eur J Med Chem 2019
Detection of novel mutations associated with independent resistance and cross-resistance to isoniazid and prothionamide in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.cmi.2018.12.008 Clin Microbiol Infect 2019
A comprehensive analysis of the protein-ligand interactions in crystal structures of Mycobacterium tuberculosis EthR. doi:10.1016/j.bbapap.2018.12.003 names it Biochim Biophys Acta Proteins Proteom 2019
Integrated analysis of ethionamide resistance loci in Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.tube.2018.08.010 Tuberculosis (Edinb) 2018
Efficient analoging around ethionamide to explore thioamides bioactivation pathways triggered by boosters in Mycobacterium tuberculosis. doi:10.1016/j.ejmech.2018.09.038 Eur J Med Chem 2018
Fragment-based approaches to TB drugs. doi:10.1017/S0031182016001876 Parasitology 2018
New active leads for tuberculosis booster drugs by structure-based drug discovery. doi:10.1039/c7ob00910k Org Biomol Chem 2017
Target Identification of Mycobacterium tuberculosis Phenotypic Hits Using a Concerted Chemogenomic, Biophysical, and Structural Approach. doi:10.3389/fphar.2017.00681 Front Pharmacol 2017
Whole-Transcriptome and -Genome Analysis of Extensively Drug-Resistant Mycobacterium tuberculosis Clinical Isolates Identifies Downregulation of ethA as a Mechanism of Ethionamide Resistance. doi:10.1128/AAC.01461-17 Antimicrob Agents Chemother 2017
Cyclic di-GMP regulates Mycobacterium tuberculosis resistance to ethionamide. doi:10.1038/s41598-017-06289-7 Sci Rep 2017
Reviving a Drug for Tuberculosis? doi:10.1056/NEJMcibr1703502 N Engl J Med 2017
Fragment Screening against the EthR-DNA Interaction by Native Mass Spectrometry. doi:10.1002/anie.201702888 names it Angew Chem Int Ed Engl 2017
EthA/R-Independent Killing of Mycobacterium tuberculosis by Ethionamide. doi:10.3389/fmicb.2017.00710 Front Microbiol 2017
Structural analysis of the interaction between spiroisoxazoline SMARt-420 and the Mycobacterium tuberculosis repressor EthR2. doi:10.1016/j.bbrc.2017.04.074 Biochem Biophys Res Commun 2017
Fragment-Sized EthR Inhibitors Exhibit Exceptionally Strong Ethionamide Boosting Effect in Whole-Cell Mycobacterium tuberculosis Assays. doi:10.1021/acschembio.7b00091 names it ACS Chem Biol 2017
Reversion of antibiotic resistance in Mycobacterium tuberculosis by spiroisoxazoline SMARt-420. doi:10.1126/science.aag1006 Science 2017
Structural insights into the EthR-DNA interaction using native mass spectrometry. doi:10.1039/c7cc00804j names it Chem Commun (Camb) 2017
AceDRG: a stereochemical description generator for ligands. doi:10.1107/S2059798317000067 Acta Crystallogr D Struct Biol 2017
Targeting tuberculosis using structure-guided fragment-based drug design. doi:10.1016/j.drudis.2016.10.003 Drug Discov Today 2017
Investigation of isoniazid and ethionamide cross-resistance by whole genome sequencing and association with poor treatment outcomes of multidrug-resistant tuberculosis patients in South Africa. doi:10.1016/j.ijmyco.2016.11.020 Int J Mycobacteriol 2016
The in vitro mechanisms of isoniazid and ethionamide resistance poorly reflect those in vivo in Mycobacterium tuberculosis. doi:10.1016/j.tube.2016.09.028 Tuberculosis (Edinb) 2016
A fragment merging approach towards the development of small molecule inhibitors of Mycobacterium tuberculosis EthR for use as ethionamide boosters. doi:10.1039/c5ob02630j names it Org Biomol Chem 2016
Second-line anti-tuberculosis drug resistance and its genetic determinants in multidrug-resistant Mycobacterium tuberculosis clinical isolates. doi:10.1016/j.jmii.2015.04.003 J Microbiol Immunol Infect 2016
Genotypic Analysis of Genes Associated with Independent Resistance and Cross-Resistance to Isoniazid and Ethionamide in Mycobacterium tuberculosis Clinical Isolates. doi:10.1128/AAC.01028-15 Antimicrob Agents Chemother 2015
Compounds for use in the treatment of mycobacterial infections: a patent evaluation (WO2014049107A1). doi:10.1517/13543776.2015.1021333 Expert Opin Ther Pat 2015
Ligand efficiency driven design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging, and linking approaches. doi:10.1021/jm500422b names it J Med Chem 2014
The Mycobacterium tuberculosis transcriptional repressor EthR is negatively regulated by Serine/Threonine phosphorylation. doi:10.1016/j.bbrc.2014.03.074 names it Biochem Biophys Res Commun 2014
An ethA-ethR-deficient Mycobacterium bovis BCG mutant displays increased adherence to mammalian cells and greater persistence in vivo, which correlate with altered mycolic acid composition. doi:10.1128/IAI.01332-13 names it Infect Immun 2014
Unconventional surface plasmon resonance signals reveal quantitative inhibition of transcriptional repressor EthR by synthetic ligands. doi:10.1016/j.ab.2014.02.011 names it Anal Biochem 2014
A structure-guided fragment-based approach for the discovery of allosteric inhibitors targeting the lipophilic binding site of transcription factor EthR. doi:10.1042/BJ20131127 names it Biochem J 2014
Structural and docking studies of potent ethionamide boosters. doi:10.1107/S0108270113028126 Acta Crystallogr C 2013
The underling mechanism of bacterial TetR/AcrR family transcriptional repressors. doi:10.1016/j.cellsig.2013.04.003 Cell Signal 2013
Discovery of novel N-phenylphenoxyacetamide derivatives as EthR inhibitors and ethionamide boosters by combining high-throughput screening and synthesis. doi:10.1021/jm300377g names it J Med Chem 2012
Structural activation of the transcriptional repressor EthR from Mycobacterium tuberculosis by single amino acid change mimicking natural and synthetic ligands. doi:10.1093/nar/gkr1113 names it Nucleic Acids Res 2012
Phenylethyl butyrate enhances the potency of second-line drugs against clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.05649-11 Antimicrob Agents Chemother 2012
Ethionamide boosters. 2. Combining bioisosteric replacement and structure-based drug design to solve pharmacokinetic issues in a series of potent 1,2,4-oxadiazole EthR inhibitors. doi:10.1021/jm200825u names it J Med Chem 2012
Ethionamide boosters: synthesis, biological activity, and structure-activity relationships of a series of 1,2,4-oxadiazole EthR inhibitors. doi:10.1021/jm200076a names it J Med Chem 2011
Molecular investigation of resistance to the antituberculous drug ethionamide in multidrug-resistant clinical isolates of Mycobacterium tuberculosis. doi:10.1128/AAC.01030-10 Antimicrob Agents Chemother 2011
Exploring drug target flexibility using in situ click chemistry: application to a mycobacterial transcriptional regulator. doi:10.1021/cb100177g ACS Chem Biol 2010
Cytochromes P450-mediated degradation of fuel oxygenates by environmental isolates. doi:10.1111/j.1574-6941.2010.00847.x FEMS Microbiol Ecol 2010
Synthetic EthR inhibitors boost antituberculous activity of ethionamide. doi:10.1038/nm.1950 names it Nat Med 2009
A synthetic mammalian gene circuit reveals antituberculosis compounds. doi:10.1073/pnas.0800663105 Proc Natl Acad Sci U S A 2008
Insights into mechanisms of induction and ligands recognition in the transcriptional repressor EthR from Mycobacterium tuberculosis. doi:10.1016/j.tube.2005.07.005 names it Tuberculosis (Edinb) 2006
The TetR family of transcriptional repressors. doi:10.1128/MMBR.69.2.326-356.2005 Microbiol Mol Biol Rev 2005
Structure of EthR in a ligand bound conformation reveals therapeutic perspectives against tuberculosis. doi:10.1016/j.molcel.2004.09.020 names it Mol Cell 2004
Crystal structure of the TetR/CamR family repressor Mycobacterium tuberculosis EthR implicated in ethionamide resistance. doi:10.1016/j.jmb.2004.06.003 names it J Mol Biol 2004
EthR, a repressor of the TetR/CamR family implicated in ethionamide resistance in mycobacteria, octamerizes cooperatively on its operator. doi:10.1046/j.1365-2958.2003.03809.x names it Mol Microbiol 2004
Ethionamide activation and sensitivity in multidrug-resistant Mycobacterium tuberculosis. doi:10.1073/pnas.97.17.9677 Proc Natl Acad Sci U S A 2000
Activation of the pro-drug ethionamide is regulated in mycobacteria. doi:10.1074/jbc.M003744200 J Biol Chem 2000

Title+abstract index only: a paper that names this gene solely in its body text, a figure legend or a supplement is invisible here. That is why this list sits beside the curated layer rather than replacing it - Rv0007's characterisation, found by a full-text sweep, returns zero in this one. Absence from this list is not absence from the literature. Source: PubMed E-utilities sweep (esearch + esummary), every alias of the gene searched in conjunction with a mycobacterial context term; ambiguous common-word aliases excluded. phase198, 2026-09-06.

This layer CITES the literature and adds context; it does not change the verdict or the function stated elsewhere in this fiche. This distinguishes a gene that is dark because nobody has looked from one that is dark despite having been studied. Source: PubMed (whole): H37Rv locus tag + GENE NAME + ortholog identifiers (Mb…, MMAR_…, MSMEG_…, ML…, MAB_…), under a mycobacterial context filter; hits verified against the abstract text. Species-context counts distinguish M. tuberculosis literature from literature on other mycobacteria. phase76/phase77, 2026-07-13.

Conditional expression context (iModulons)

Member of 1 independently-modulated gene set(s): Unc_2.

iModulon membership (independently-modulated gene sets from a 647-sample RNA-seq compendium): the conditional co-expression context. Co-expression is a regulatory context, NOT a molecular function. Source: iModulonDB / modulome_mtb (Yoo 2022).

CRISPRi vulnerability

Vulnerability index 1.03 (95% CI -0.94 to 4.31). A more negative index = more vulnerable to knockdown (better drug-target quality); indicative threshold VI ≤ -6 = highly vulnerable.

Quantitative CRISPRi knockdown, graded (finer than binary Tn-seq essentiality). Source: CRISPRi vulnerability index (Bosch 2021, supplementary Table S2 'mmc3.xlsx', bulk import via Europe PMC -- supersedes the per-gene pebble.rockefeller.edu scrape of phase46_crispri_vulnerability.py).

Caveat on this estimate. Bosch et al. flag this gene's vulnerability estimate as NOT certain, and here that call has a mechanical cause visible in the library itself: every guide targeting this gene is >=21 nt (str_span=0.064 on a 0-1 scale, near the genome floor), and guide repression strength saturates from 21 nt on -- so the library never sampled a partial knockdown for this gene, only the near-maximal repression plateau. The dose-response fit (and this VI) is therefore essentially unconstrained by data, not merely uncertain -- a limitation of the CRISPRi library design for the non-essential class (Bosch et al. 2021), not a defect in this specific measurement. n_guides=5 is descriptive only and does not predict this. Do not cite this VI as a standalone vulnerability claim.

Legacy record & comparison (Mycobrowser)

Mycobrowser functionRegulates negatively the production of ETHA. Induced ETH resistance when overexpressed in Mycobacterium tuberculosis.

The legacy Mycobrowser record is shown for verification. Mycobrowser is no longer maintained; its EC numbers predate recent nomenclature revisions, so a class change usually reflects re-numbering, not a conflict.

Orthologues (reciprocal best hits across mycobacteria)

M. bovis Mb3885 · 99.5% identity
M. leprae ML0064c · 76.4% identity
M. marinum MMAR_5405 · 78.2% identity
M. smegmatis MSMEG_6441 · 63.2% identity
M. orygis RJtmp_003971 · 99.5% identity
M. abscessus MAB_0984c · 53.2% identity

Reciprocal-best-hit orthologues (DIAMOND) against the Mycobrowser reference proteomes. A missing species is informative: e.g. a gene absent from M. leprae was likely lost in its reductive genome evolution. Locus tags link to Mycobrowser.

Curated reference (UniProt)

UniProt P9WMC1 SwissProt · reviewed · Evidence at protein level
UniProt nameHTH-type transcriptional regulator EthR
Curated functionInvolved in the repression of the monooxygenase EthA which is responsible of the formation of the active metabolite of ethionamide (ETH).

Functional vocabulary (eggNOG-mapper, orthology transfer)

COG category K Transcription
Preferred nameethR
eggNOG descriptionTranscriptional regulator
Orthologous groupCOG1309
KEGG orthology K21961
Gene Ontology (60) GO:0000976, GO:0001067, GO:0003674, GO:0003676, GO:0003677, GO:0003690, GO:0003700, GO:0005488, GO:0005575, GO:0005622, GO:0005623, GO:0005737 +48 more

Orthology-based transfer (eggNOG 5.0.2, diamond). EC/KO/GO/CAZy are computed annotations, not manual curation; cross-check against the primary literature before treating a specific reaction as established.

Conservation & selection (intra-MTBC, 142 601 strains, snapshot of 2026-09-29)

pN/pS 0.526 · quasi-invariant (5 sites), pN/pS underpowered
Polymorphic sites (≥ 0.1% of strains) 2 synonymous, 3 missense, 0 nonsense, 0 frameshift

pN/pS from segregating SNPs (singletons removed) normalised by possible sites. Low pN/pS = purifying selection (a strong signal that a "hypothetical" is a real, constrained gene). A high pN/pS is ambiguous: relaxed constraint or positive selection (drug resistance, antigenic variation) inflate it; e.g. rpoB/katG/pncA score high here for resistance, not loss of function. A clonal disruption (one allele over a clade) suggests lineage pseudogenisation; a convergent one (many independent alleles) is typical of resistance loss-of-function.

Outgroup conservation (beyond the MTBC) Actinomycetia

Genus-wide presence (~53 non-MTBC Mycobacterium) present in 53/53 (100%) · mean identity 69.5% · 4/4 closest MTBAP relatives
conserved across the genus (present in 53/53 non-MTBC Mycobacterium genomes, incl. distant relatives) — an ancient core gene predating the genus radiation
Phylostratum (deepest detected homolog) MTBC-specific → Mycobacterium → Mycobacteriaceae → Corynebacteriales → Actinomycetia → Bacteria
detected in 4/13 non-Mycobacterium reference genomes (down to Actinomycetia) · mean identity 38.0%
detected across the class Actinomycetia (beyond Corynebacteriales) but not outside the phylum — an Actinobacteria-level ancient gene

Two orthogonal outgroup signals. M. canettii (the immediate outgroup) gives a deep-divergence dN/dS (a low value confirms a constrained, real gene; shown as confident only at ≥8 substitutions, else flagged low-power). Genus-wide presence/absence (tblastn vs assembled non-MTBC genomes) places the gene on the ancient-core ↔ MTBC-specific axis: a gene absent even from the closest MTBAP relatives is a candidate MTBC-specific innovation (possible host-adaptation factor, to confirm by synteny). The phylostratum extends that axis outside the genus (tblastn vs 13 reference genomes spanning Mycobacteriaceae → Corynebacteriales → Actinomycetia → outside the phylum): it is the deepest clade in which a homolog is still detected, i.e. a proxy for gene age. Read it with the null model in mind: a shallow (young) stratum can also reflect homology-detection failure for short or fast-evolving ORFs, so it is a descriptive axis, not a proof of novelty.

Essentiality (transposon mutagenesis)

DeJesus 2017 callNE · non-essential
What the call meansnon-essential
TA sites (Himar1) 12 in the ORF — 0 in the essential state, 0 growth-defect, 12 non-essential, 0 growth-advantage. Saturation 1.000, mean read count 83.0833333333. A region of the protein devoid of TA sites is invisible to this assay: nothing can be inferred about it, in either direction.
All 12 sites lie in this ORF alone (no overlapping CDS shares any), so the call is attributable to this gene.

Genome-wide Himar1 transposon essentiality in H37Rv (DeJesus 2017). An essential call (ES/ESD/GD) is strong, independent evidence that a "hypothetical" locus encodes a functional, selectively required gene — orthogonal to intra-species conservation.

Mutant phenotypes (conditional Tn-seq, MtbTnDB)

Conditionlog2FCqEffect
altered fitness under nitrosative (NO) stress (stress) -2.900.0 required
altered fitness under acid stress in phosphate-citrate buffer (stress) -2.200.0078 required
differential fitness in a comparison whose nature could not be established (upstream metadata defect, see note) (undetermined) +1.130.0083 disruption advantageous

Conditional fitness of transposon-disruption mutants across 3 significant condition(s) (|log2FC|≥1, q≤0.05), from the standardized MtbTnDB compendium. A negative log2FC means the mutant is depleted — the gene contributes to fitness in that condition. An in-vivo defect for a "hypothetical" is strong evidence it matters for infection, even without a known molecular function. Disruption (Tn insertion), not a clean deletion; genetic-interaction screens excluded.

Provenance note on a condition above. MtbTnDB labels this condition in vivo (Collaborative Cross mouse panel) and attributes it to Smith et al. 2022, eLife 74419. Both are wrong and for the same reason: its left arm, `mbio_H37Rv`, is the saturated H37Rv reference of DeJesus et al. 2017 (mBio 8(1):e02133-16, fourteen independent Tn libraries grown in standard medium), not a mouse strain, and the upstream generator read the token before `_vs_` as a mouse-strain name. The same sample is the in vitro control of six knockout screens in the same file. Measured here on rank correlation over 3971 genes: this condition tracks the other 81 first-order in vivo conditions at rho = +0.03, where those conditions track each other at +0.270 -- it does not behave like an infection measurement. What the comparison actually is could not be established, so it is reported as undetermined rather than renamed, and it is excluded from the in vivo count of this fiche.

Proteomics (mass spectrometry) detected

MS detectiondetected in 13 of 16 independent MS datasets
Integrated abundance39.0 ppm · rank 1920/3519 (45.5th percentile)

Detection by mass spectrometry is direct, experimental evidence that the protein product exists — orthogonal to sequence conservation and to Tn-seq essentiality, and especially decisive for a "hypothetical" locus. Read the dataset count as abundance, not as replication. Measured across this atlas (3,491 detected proteins), the number of datasets a protein appears in tracks its abundance almost monotonically: median 1.2 ppm at 1 dataset of 16, 27 ppm at 10, 392 ppm at 15, 1,325 ppm at 16 — three orders of magnitude. A high count therefore says the protein is abundant more than it says several independent experiments confirmed it. What the count does establish, at any value, is that the product exists.

Predicted localisation (DeepTMHMM + lipobox) no export signal, no TM helix

Predictionno signal peptide, no TM helix (DeepTMHMM class GLOB)
DeepTMHMM classGLOB

A verified absence of signals, which is not a compartment. No Sec/Tat signal peptide, no transmembrane helix and no lipobox were found on this sequence. The predictor reports topology and export signals; it does not measure where the protein ends up, so this page draws no cytoplasmic conclusion from it. In M. tuberculosis that reservation is not theoretical: the 12 Esx paralogues of this atlas — EsxA/ESAT-6 and EsxB/CFP-10 among them, the best-established secreted proteins of the species — carry this very call, because substrates of the type VII (ESX) secretion system leave no recognisable signal. « Secreted » and « no signal peptide » are true together here.

Transmembrane topology and signal peptide from DeepTMHMM (deep-learning reference predictor); lipoproteins from a (myco)bacterial lipobox motif. A sequence-based prediction of subcellular context.

Physico-chemical properties (computed, ProtParam)

Length216 aa
Molecular weight23.8 kDa
Theoretical pI5.16
GRAVY-0.191 (hydrophilic)
Aliphatic index85.1
Aromaticity0.079
Instability index28.5 (stable)

Computed from the ancestral MTBC0 sequence with the ExPASy ProtParam method (Biopython). Descriptive biophysical context: a positive GRAVY flags a hydrophobic (often membrane) protein, a high instability index (>40) predicts a short in-vitro half-life, an extreme pI hints at compartment or binding partner.

Domains (Pfam, hmmscan --cut_ga)

PfamAccessioni-EvalueResiduesDescription
TetR_NPF00440.30 5.8e-1329–73 Bacterial regulatory proteins, tetR family
EthR_CPF21313.3 3.1e-52103–213 Transcriptional regulator EthR, C-terminal domain

3D structure (interactive — Mol*/pdbe-molstar)

Experimental structure 7ngg (PDBe), the strongest available structural evidence for this gene. Drag to rotate, scroll to zoom; hetero-groups (ligands, ions, waters hidden by default) shown as sticks.

Experimental structures (Protein Data Bank) 88 solved

PDBMethodResolutionCoverage
7ngg X-ray diffraction 1.17 Å 100%
7ngx X-ray diffraction 1.24 Å 100%
7ngu X-ray diffraction 1.26 Å 100%
7ngw X-ray diffraction 1.26 Å 100%
7ngy X-ray diffraction 1.27 Å 100%
5nio X-ray diffraction 1.4 Å 100%
7ngd X-ray diffraction 1.47 Å 100%
5nim X-ray diffraction 1.5 Å 100%

Experimentally solved structures mapped from the UniProt accession via PDBe/SIFTS (88 total; up to 8 shown, ranked by sequence coverage then resolution). An experimental structure is direct proof of the folded product and the strongest structural evidence — superseding the predicted ESMFold/AlphaFold models below for any covered region.

Structural search (AlphaFold DB model, Foldseek vs PDB — genome-wide) pLDDT 91.9

PDB hitprobTM (aln)TM (query)TM (target)Seq. id.Cov. q / tE-valueDescription
5nim-assembly1_A 1.00 0.99 0.90 0.99 100% 91% / 100% 6.2e-25 sig 5nim-assembly1_A EthR complex
5nz0-assembly1_A-2 1.00 1.00 0.88 1.00 98% 89% / 100% 5.1e-24 sig 5nz0-assembly1_A-2 Structure of Transcriptional Regulatory Repressor Protein - EthR from Mycobacterium Tuberculosis in complex with linezolid
5mym-assembly2_C 1.00 0.93 0.89 0.93 100% 95% / 100% 4.7e-25 sig 5mym-assembly2_C Structure of Transcriptional Regulatory Repressor Protein - EthR from Mycobacterium Tuberculosis in complex with compound GSK2032710A at 2.28A resolution
6ho0-assembly1_A-2 1.00 0.99 0.86 0.99 98% 88% / 100% 9.7e-24 sig 6ho0-assembly1_A-2 TRANSCRIPTIONAL REPRESSOR ETHR FROM MYCOBACTERIUM TUBERCULOSIS IN COMPLEX WITH BDM41325
4m3g-assembly1_A-2 1.00 0.99 0.88 0.99 98% 89% / 100% 1.5e-23 sig 4m3g-assembly1_A-2 Rapid and efficient design of new inhibitors of Mycobacterium tuberculosis transcriptional repressor EthR using fragment growing, merging and linking approaches

Foldseek search of the AlphaFold DB model (mean pLDDT 91.9, gated at 70) against the PDB — a genome-wide extension of the ESMFold dark-gene search that also covers proteins beyond the single-sequence length limit. Confident structural neighbours (E < 0.01) shown.

Genomic context (neighbours & predicted operon)

Upstream (5' on genome)ethA (- strand, 75 bp gap)
Downstream (3' on genome)Rv3856c (- strand, 201 bp gap)

Neighbours from the H37Rv annotation (+ strand). The operon is predicted by co-directional intergenic distance (same strand, gaps ≤50 bp) — a transcription-unit hypothesis, not a mapped TSS. For a "hypothetical", co-transcription with a characterised operon is a concrete functional lead (complements the STRING neighborhood channel below).

Published operon evidence (two independent sources)

Roback 2007 (logistic regression: distance + expression correlation, 474 microarrays) no multi-gene operon predicted (singleton)
REMap 2016 (RNA-seq coverage continuity, CDC1551, tag MT3970) expressed, no multi-gene operon (exponential phase, coverage 50.96)
expressed, no multi-gene operon (stationary phase, coverage 30.08) — agrees with the distance heuristic above

Two independent published operon maps, cited alongside the distance heuristic above: an association corroborating or contradicting the heuristic, never proof of shared function. REMap's RNA-seq coverage continuity is the most direct of the three signals; Roback's logistic regression and the intergenic-distance heuristic are statistical proxies.

Transcriptional regulation (signed TRN: ChIP-seq + TFOE) transcription factor

Regulated by (3 TF) Rv2250c (represses) · Rv3249c (represses) · ethR (activates)
Regulonthis transcription factor regulates 8 target gene(s)

Regulatory edges from the ISB signed transcriptional regulatory network (TF ChIP-seq binding, Minch 2015 + TF-overexpression response, Rustad 2014). An edge is regulatory evidence (binding and/or expression change), not necessarily direct. For a "hypothetical", membership in a known regulon (e.g. DosR dormancy, PhoP virulence) is a physiological-context lead, not a function.

Condition: Condition-blind by construction. These edges come from transcription-factor OVEREXPRESSION in a single laboratory condition, so a listed regulator is not a claim that it governs this gene in every circumstance. Measured counter-examples exist within this atlas (see Rv2516c, where the DosR regulon collapses under moxifloxacin while the gene itself rises). Read a regulator as 'capable of shifting this gene', and look for the condition before building a hypothesis on it.

Functional interaction network (STRING v12, guilt-by-association)

Explore full network →

Node colour = verdict, dashed = still uncharacterised; edge colour = evidence (green experimental, orange genomic-context, grey co-expression), width ∝ score. Click a partner to open its page; "Explore full network" to walk the graph.

Showing the 15 strongest of this gene's 57 partners at medium confidence (24 at high confidence). The table is an extract, not a neighbourhood: across the proteome the real median degree is 34 while the served median is 15, so no hub, degree distribution or centrality may be read on this table. None of the 57 partners rests on an interaction measured in M. tuberculosis itself.

PartnerProductScoreNo text-miningChannels (≥400)
Rv0158 transcriptional regulator 869 869 coexpression:802
Rv3060c GntR family transcriptional regulator 842 837 coexpression:837
Rv1985c lysG HTH-type transcriptional regulator 833 831 coexpression:810
Rv0624 vapC30 ribonuclease VapC30 799 799 coexpression:799
Rv1019 transcriptional regulator 799 799 coexpression:799
Rv3183 higA3 transcriptional regulator 797 797 coexpression:797
Rv3263 DNA methylase 793 793 coexpression:793
Rv3557c kstR2 HTH-type transcriptional regulator KstR2 791 778 coexpression:748
Rv0691c mftR mycofactocin biosynthesis transcriptional regulator MftR 782 776 coexpression:731
Rv3840 transcriptional regulator 767 767 coexpression:767
Rv3736 AraC/XylS family transcriptional regulator 768 765 coexpression:765
Rv1960c parD1 antitoxin ParD1 765 765 coexpression:765
Rv3167c TetR family transcriptional regulator 779 753 coexpression:716
Rv0339c iniR transcriptional regulator 734 734 coexpression:734
Rv1776c transcriptional regulator 734 734 coexpression:734

STRING combines evidence channels (neighborhood, fusion, cooccurrence, coexpression, experimental, database, text-mining) into a 0–1000 score. The ctx badge marks edges carried by the genomic-context channels (conserved neighborhood, fusion, phylogenetic co-occurrence), which are independent of orthology and structure and the strongest signal for an unknown gene. The no text-mining column recomputes the score from data alone, so a link that does not depend on the literature is visible. Association is a function hypothesis, not proof: corroborate with the operon context and the primary literature before assigning a function.

Where the experimental evidence comes from, and why it matters here. STRING's experimental channel fuses interactions measured in M. tuberculosis with interactions measured in another organism and transferred to this pair by orthology. The two are not equivalent for this atlas, whose standing rule is that better studied elsewhere is not a function established in M. tuberculosis. Measured on the served network: of the 38 229 partner pairs shown across the atlas, 13 483 partner rows carry a non-zero experimental channel, and only 106 pairs rest on an interaction measured in M. tuberculosis itself — 0.3 % of the network. Those 106 are long-established complexes (ESX-1/ESAT-6, RNA polymerase with CarD and RbpA, the Pup–Mpa proteasome, gyrase, Emb, GarA with PknB and PknG, the Rel modules); no still-uncharacterised gene is among them. The reason is not a gap in this atlas but in the literature: there is almost no experimental interactome of this bacterium, IntAct holding 134 curated protein pairs for a ~4 000-gene proteome. A exp (transferred) badge is therefore a lead, never a measurement, and an absence of badge is not evidence that the pair does not interact.

Evidence

  • Legacy H37Rv annotation: HTH-type transcriptional repressor EthR
  • MTBC0 PGAP product: HTH-type transcriptional regulator EthR
  • Pfam (hmmscan --cut_ga): TetR_N PF00440.30 (E=6e-13), EthR_C PF21313.3 (E=3e-52)
  • (auto-curated by rules from PGAP + Pfam + Foldseek; not hand-reviewed)

Sources

  • Ancestral sequence & coordinates: Harrison LB et al. (2024), An imputed ancestral reference genome for the MTBC, doi:10.1101/2023.09.07.556366
  • Product annotation: NCBI PGAP on MTBC0; legacy from H37Rv NC_000962.3 (RefSeq NP_218372.1)
  • Domains: Pfam-A via hmmscan --cut_ga — TetR_N (PF00440.30), EthR_C (PF21313.3)
  • Sequence-level signal: ESM Atlas (EvolutionaryScale × BioHub) — exploratory
  • Controlled vocabulary: eggNOG-mapper 2.1.12 (Cantalapiedra et al. 2021, doi:10.1093/molbev/msab293), eggNOG 5.0 DB (Huerta-Cepas et al. 2019) — OG COG1309
  • Curated reference: UniProt P9WMC1 (SwissProt, reviewed; Evidence at protein level)
  • Intra-MTBC selection: pN/pS and disruption from SPDI variants of 142 601 MTBC strains (this work, local collection vs H37Rv NC_000962.3)
  • Genome-wide structure: AlphaFold DB model (Jumper et al. 2021, doi:10.1038/s41586-021-03819-2; Varadi et al. 2024, doi:10.1093/nar/gkad1011) searched vs PDB with Foldseek (mean pLDDT 91.9)
  • Interaction network: STRING v12.0 (Szklarczyk et al. 2023, doi:10.1093/nar/gkac1000), taxon 83332, CC-BY 4.0 — 57 functional partner(s)
  • Essentiality: genome-wide transposon mutagenesis in H37Rv — DeJesus et al. 2017 (mBio, doi:10.1128/mBio.02133-16, CC BY)
  • Proteomics: integrated mass-spectrometry abundance from PaxDb 5.0 (Huang et al. 2023, doi:10.1016/j.mcpro.2023.100640), taxon 83332 — weighted average of 16 datasets, incl. Schubert et al. 2013 (doi:10.1016/j.chom.2013.04.008) and Albrethsen et al. 2013 (doi:10.1074/mcp.M112.018846)
  • Functional category: TubercuList scheme (Cole et al. 1998, doi:10.1038/31159), via Mycobrowser (Kapopoulou et al. 2011, doi:10.1016/j.tube.2010.09.006)
  • Orthologues: reciprocal best hits (DIAMOND, Buchfink et al. 2021, doi:10.1038/s41592-021-01101-x) against Mycobrowser release 5 reference proteomes
  • Experimental structures: PDBe/SIFTS UniProt→PDB mapping (Dana et al. 2019, doi:10.1093/nar/gky1114)
  • Genomic context / operon: H37Rv annotation; operon predicted by co-directional intergenic distance (Salgado et al. 2000, doi:10.1073/pnas.030539397)
  • Transcriptional regulation: ISB signed TRN — TF ChIP-seq (Minch et al. 2015, doi:10.1038/ncomms6829) + TF overexpression (Rustad et al. 2014, doi:10.1186/gb-2014-15-11-502)
  • Mutant phenotypes: standardized Tn-seq compendium MtbTnDB (Jinich et al. 2025, doi:10.1111/mmi.15370), aggregating many primary Tn-seq studies across conditions
  • Physico-chemical properties: ExPASy ProtParam method via Biopython (Gasteiger et al. 2005), computed from the MTBC0 sequence
  • Predicted localisation: DeepTMHMM (Hallgren et al. 2022, doi:10.1101/2022.04.08.487609) for transmembrane topology and signal peptide
  • Primary literature: none located yet; annotation rests on the domain/homology sources above.

Ancestral MTBC0 protein sequence

>mtbc0_004088|Rv3855|ethR
MTTSAASQASLPRGRRTARPSGDDRELAILATAENLLEDRPLADISVDDLAKGAGISRPTFYFYFPSKEAVLLTLLDRVVNQADMALQTLAENPADTDRENMWRTGINVFFETFGSHKAVTRAGQAARATSVEVAELWSTFMQKWIAYTAAVIDAERDRGAAPRTLPAHELATALNLMNERTLFASFAGEQPSVPEARVLDTLVHIWVTSIYGENR